Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey (Q44743374)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey |
scientific article published in February 2004 |
Statements
1 reference
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey (English)
1 reference
Keith W Ward
1 reference
Gary J Stelman
1 reference
Jayme A Morgan
1 reference
Kelli S Zeigler
1 reference
Leonard M Azzarano
1 reference
Jonathan R Kehler
1 reference
Jeanelle E McSurdy-Freed
1 reference
Joel W Proksch
1 reference
Brian R Smith
1 reference
1 February 2004
1 reference
1 reference
32
1 reference
2
1 reference
172-177
1 reference
Identifiers
1 reference
1 reference